Insulin manufacturers reduce prices globally within 12 months

Market overview

If the U.S. caps insulin prices at $35/month, global manufacturers (e.g., Novo Nordisk, Sanofi) will voluntarily reduce prices in other markets to align with U.S. standards. This will trigger similar regulatory pressure in Europe and Canada.

adoption prediction market

Implied probability (Yes)

60%

Source: user-generated

More adoption markets

• Daily active crypto users surpass 100 million by mid-2026 — 60% Yes
• Kalshi’s market share in crypto derivatives surpasses 5% by Q4 2027 — 55% Yes
• Kalshi's crypto perpetual futures launch by 2026-Q4 — 75% Yes
• Family offices double down on crypto-adjacent mining firms within 6 months — 72% Yes
• Nigeria's crypto transaction volume exceeds $5B in 2026 — 80% Yes
• AI and crypto groups increase political ad spending in 2026 midterms — 80% Yes
• Crypto and AI groups double political ad spending by 2027 — 75% Yes
• Crypto billionaire Harborne will increase donations to Farage by 20% by Mar 2027 — 60% Yes

Browse all adoption markets →